Pharmacotherapeutic strategies for pediatric bipolar disorder

Bibliography

• GELLER B, LUBY J: Child and adolescent bipolar disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry (1997) 36(9):1168-1176.
   PubMed Web of Science ®Google Scholar
• MCLELLAN J: Commentary: treatment guidelines for child and adolescent bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(3):236-239.
   PubMedGoogle Scholar
• GELLER B, BOLHOFNER K, CRANEY J et al.: Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J. Am. Acad. Child Adolesc. Psychiatry (2000) 39(12):1543-1548.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, DELBELLO MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc. Psychiatr Clin. N. Am. (2006) 15(1):73-108.
   PubMed Web of Science ®Google Scholar
• SIMKIN DR: Adolescent substance use disorders and comorbidity. Pediatr. Clin. North Am. (2002) 49(2):463-477.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN TR, BIRMAHER B, AXELSON D et al.: History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. (2005) 7(6):525-535.
   PubMed Web of Science ®Google Scholar
• LEWINSOHN PM, KLEIN DN, SEELEY JR: Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J. Am. Acad. Child Adolesc. Psychiatry (1995) 34(4):454-463.
   PubMed Web of Science ®Google Scholar
• YOUNGSTROM EA, DAUX J: Evidence-based assessment of pediatric bipolar disorder, Part I: base rate and family history. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(7):712-717.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, DELBELLO MP: Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr. Clin. North Am. (2005) 28(2):385-397.
   PubMed Web of Science ®Google Scholar
• MARCHAND WR, WIRTH L, SIMON C: Delayed diagnosis of pediatric bipolar disorder in a community mental health setting. J. Psychiatr. Pract. (2006) 12(2):128-133.
   PubMedGoogle Scholar
• GELLER B, CRANEY JL, BOLHOFNER K, DELBELLO MP, WILLIAMS M, ZIMERMAN B: One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry (2001) 158(2):303-305.
   PubMed Web of Science ®Google Scholar
• GELLER B, TILLMAN R, CRANEY JL, BOLHOFNER K: Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch. Gen. Psychiatry (2004) 61(5):459-467.
   PubMed Web of Science ®Google Scholar
• AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorder, 4th Edition (DSM-IV). American Psychiatric Association, Washington, DC. (1994).
   Google Scholar
• WOZNIAK J, BIEDERMAN J, KWON A et al.: How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol. Psychiatry (2005) 58(7):583-588.
   PubMed Web of Science ®Google Scholar
• DILSAVER SC, BENAZZI F, AKISKAL HS: Mixed states: the most common outpatient presentation of bipolar depressed adolescents? Psychopathology (2005) 38(5):268-272.
   PubMedGoogle Scholar
• BIRMAHER B, AXELSON D, STROBER M et al.: Clinical course of children and adolescents with bipolar spectrum disorders. Arch. Gen. Psychiatry (2006) 63:175-183.
   PubMed Web of Science ®Google Scholar
• AXELSON D, BIRMAHER B, STROBER M et al.: Phenomenology of children and adolescents with bipolar spectrum disorders. Arch. Gen. Psychiatry (2006) 63(10):1139-1148.
   PubMed Web of Science ®Google Scholar
• LEIBENLUFT E: Flying almost blind. Am. J. Psychiatry (2006) 163(7):1129-1131.
   PubMed Web of Science ®Google Scholar
• LEIBENLUFT E, CHARNEY DS, TOWBIN KE, BHANGOO RK, PINE DS: Defining clinical phenotypes of juvenile mania. Am. J. Psychiatry (2003) 160:430-437.
   PubMed Web of Science ®Google Scholar
• PUIG-ANTICH J, CHAMBERS W: Schedule for Affective Disorders and Schizophrenia for School-Age Children (KIDDIE-SADS). New York State Psychiatric Institute, Biometrics Research, New York (1978).
   Google Scholar
• GELLER B, WARNER K, WILLIAMS M et al.: Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J. Affect. Disord. (1998) 51(2):93-100.
   PubMed Web of Science ®Google Scholar
• SHAFFER D, FISHER P, LUCAS CP et al.: NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J. Am. Acad. Child Adolesc. Psychiatry (2000) 39(1):28-38.
   PubMed Web of Science ®Google Scholar
• WELLER E, WELLER R, FRISTAD M et al.: Children's Interview for Psychiatric Syndromes (ChIPS). Washington (DC): American Psychiatric Press (1999).
   Google Scholar
• HIRSCHFIELD RM, HOLZER C, CALABRESE JR et al.: Validity of the mood disorder questionnaire: a general population study. Am. J. Psychiatry (2003) 160(1):178-218.
   PubMedGoogle Scholar
• YOUNG RC, BIGGS JT, ZIEGLER VE et al.: A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry (1978) 133:429-435.
   PubMed Web of Science ®Google Scholar
• PAPOLOS D, HENNEN J, COCKERHAM MS, THODE HC Jr, YOUNGSTROM EA: The child bipolar questionnaire: a dimensional approach to screening for pediatric bipolar disorder. J. Affect. Disord. (2006) 95(1-3):149-158.
   PubMed Web of Science ®Google Scholar
• SPEARING MK, POST RM, LEVERICH GS, BRANDT D, NOLEN W: Modification of the Clinical Global Impressions (CGI) scale for use with bipolar illness (BP): the CGI: BP. Psychiatry Res. (1997) 73:159-171.
   PubMed Web of Science ®Google Scholar
• GRACIOUS BL, YOUNGSTROM EA, FINDLING RL, CALABRESE JR: Discriminative validity of a parent version of the Young Mania Rating Scale. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(11):1350-1359.
   PubMed Web of Science ®Google Scholar
• DEPUE RA: General Behavior Inventory (manual) (Assessment Manual). University of Minnesota, Minneapolis, MN. (1987).
   Google Scholar
• PAVULURI M, HENRY D, DEVINENI B, CARBRAY J, BIRMAHER B: Child Mania Rating Scale: development, reliability, and validity. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45:550-560.
   PubMed Web of Science ®Google Scholar
• PAVULURI MN, BIRMAHER B, NAYLOR MW: Pediatric bipolar disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(9):846-871.
   PubMed Web of Science ®Google Scholar
• GELLER B, ZIMERMAN B, WILLIAMS M et al.: Diagnostic characteristics of 93 cases of prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. (2000) 10:157-164.
   PubMed Web of Science ®Google Scholar
• GELLER B, COOPER TB, SUN K et al.: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J. Am. Acad. Child Adolesc. Psychiatry (1998) 37(2):171-178.
   PubMed Web of Science ®Google Scholar
• KAFANTARIS V, COLETTI DJ, DICKER R, PADULA G, KANE JM: Lithium treatment of acute mania in adolescents: a large open trial. J. Am. Acad. Child Adolesc. Psychiatry (2003) 42:1038-1045.
   PubMed Web of Science ®Google Scholar
• STROBER M, MORRELL W, LAMPERT C et al.: Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am. J. Psychiatry (1990) 147(4):457-461.
   PubMed Web of Science ®Google Scholar
• BELMAKER RH, BERSUDSKY Y, AGAM G et al.: How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu. Rev. Med. (1996) 47:47-56.
   PubMed Web of Science ®Google Scholar
• MANJI HK, CHEN G: PKC, MAP kinases and the bcl-2 family of proteins as long term targets for mood stabilizers. Mol. Psychiatry (2002) 7(Suppl. 1):S46-S56.
   PubMed Web of Science ®Google Scholar
• HASHIMOTO R, TAKEI N, SHIMAZU K et al.: Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology (2002) 43(7):1173-1179.
   PubMed Web of Science ®Google Scholar
• WELLER EB, WELLER RA, FRISTAD MA: Lithium dosage guide for prepubertal children: a preliminary report. J. Am. Acad. Child Psychiatry (1986) 25(1):92-95.
   PubMedGoogle Scholar
• MOORE CM, DEMOPULOS CM, HENRY ME et al.: Brain-to-serum lithium ratio and age: an in vivo magnetic resonance spectroscopy study. Am. J. Psychiatry (2002) 159(7):1240-1242.
   PubMed Web of Science ®Google Scholar
• CAMPBELL M, SILVA RR, KAFANTARIS V et al.: Predictors of side effects associated with lithium administration in children. Psychopharmacol. Bull. (1991) 27(3):373-380.
   PubMedGoogle Scholar
• HAGINO OR, WELLER EB, WELLER RA et al.: Untoward effects of lithium treatment in children aged four through six years. J. Am. Acad. Child Adolesc. Psychiatry (1995) 34(12):1584-1590.
   PubMed Web of Science ®Google Scholar
• DANIELYAN A, KOWATCH RA: Management options for bipolar disorder in children and adolescents. Pediatr. Drugs (2005) 7(5):277-294.
   PubMedGoogle Scholar
• FINDLING RL, MCNAMARA NK, GRACIOUS BL et al.: Combination lithium and divalproex sodium in pediatric bipolarity. J. Am. Acad. Child Adolesc. Psychiatry (2003) 42(8):895-901.
   PubMed Web of Science ®Google Scholar
• GROF P, DUFFY A, CAVAZZONI P et al.: Is response to prophylactic lithium a familial trait? J. Clin. Psychiatry (2002) 63(10):942-947.
   PubMed Web of Science ®Google Scholar
• KUTCHER SP, MARTON P, KORENBLUM M: Adolescent bipolar illness and personality disorder. J. Am. Acad. Child Adolesc. Psychiatry (1990) 29(3):355-358.
   PubMed Web of Science ®Google Scholar
• CHEN G, MANJI HK, WRIGHT CB et al.: Effects of valproic acid on β-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology (1996) 15(3):271-280.
   PubMed Web of Science ®Google Scholar
• CLOYD JC, FISCHER JH, KRIEL RL et al.: Valproic acid pharmacokinetics in children: IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin. Pharmacol. Ther. (1993) 53(1):22-29.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, JANICAK PG, ORSULAK P et al.: Relation of serum valproic acid concentration to response in mania. Am. J. Psychiatr. (1996) 153(6):765-770.
   PubMed Web of Science ®Google Scholar
• ISOJARVI JI, LAATIKAINEN TJ, KNIP M et al.: Obesity and endocrine disorders in women taking valproic acid for epilepsy. Ann. Neurol. (1996) 39(5):579-584.
   PubMed Web of Science ®Google Scholar
• WAGNER KD, WELLER EB, CARLSON GA et al.: An open-label trial of divalproex in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(10):1224-1230.
   PubMed Web of Science ®Google Scholar
• SCHEFFER RE, KOWATCH RA, CARMODY T, RUSH AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am. J. Psychiatry (2005) 162(1):58-64.
   PubMed Web of Science ®Google Scholar
• HENRY CA, ZAMVIL LS, LAM C, ROSENQUIST KJ, GHAEMI SN: Long-term outcome with divalproex in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. (2003) 13(4):523-529.
   PubMed Web of Science ®Google Scholar
• CHANG KD, DIENES K, BLASEY C, ADLEMAN N, KETTER T, STEINER H: Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J. Clin. Psychiatry (2003) 64(8):936-942.
   PubMed Web of Science ®Google Scholar
• MANJI HK, MOORE GJ, CHEN G: Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry (2000) 48(8):740-754.
   PubMed Web of Science ®Google Scholar
• MANJI HK, CHEN G, HSIAO JK et al.: Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy. J. Clin. Psychiatry (1996) 57(Suppl. 13):34-46.
   PubMedGoogle Scholar
• CHANG KD, SIMEONOVA D: Mood stabilizers: use in pediatric psychopharmacology. In: Handbook of Mental Health Interventions in Children and Adolescents: An Integrated Developmental Approach. Steiner H, Chang K, Lock J, Wilson J (Eds), Jossey-Bass, New York (2004):363-412.
   Google Scholar
• REIMERS A, SKOGVOLL E, SUND JK, SPIGSET O: Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. J. Clin. Psychopharmacol. (2005) 25(4):342-348.
   PubMed Web of Science ®Google Scholar
• BOURGEOIS BF: Pharmacokinetic: properties of current antiepileptic drugs: what improvements are needed? Neurology (2000) 55(11 Suppl. 3):S11-S16.
   Google Scholar
• WOOLSTON JL: Case study: carbamazepine treatment of juvenile-onset bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(3):335-338.
   PubMed Web of Science ®Google Scholar
• HSU LK: Lithium-resistant adolescent mania. J. Am. Acad. Child Psychiatry. (1986) 25:280-283.
   PubMedGoogle Scholar
• KOWATCH RA, SUPPES T, CARMODY TJ et al.: Effect size of lithium, divalproex sodium and carbamazepine in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2000) 39(6):713-720.
   PubMed Web of Science ®Google Scholar
• TEITELBAUM M: Oxcarbazepine in bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40:993-994.
   PubMed Web of Science ®Google Scholar
• MACMILLAN CM, KORNDORFER SR, RAO S, FLEISHER CA, MEZZACAPPA E, GONZALEZ-HEYDRICH J: A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. J. Psychiatr. Pract. (2006) 12(4):214-222.
   PubMedGoogle Scholar
• WAGNER KD, KOWATCH RA, EMSLIE GJ et al.: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am. J. Psychiatry (2006) 163:1179-1786.
   PubMed Web of Science ®Google Scholar
• GUBERMAN AH, BESAG FM, BRODIE MJ et al.: Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia (1999) 40:985-991.
   PubMed Web of Science ®Google Scholar
• MESSENHEIMER J: Efficacy and safety of lamotrigine in pediatric patients. J. Child Neurol. (2002) 17(Suppl. 2):2S34-2S42.
   PubMedGoogle Scholar
• GOLDSMITH DR, WAGSTAFF AJ, IBBOTSON T, PERRY CM: Lamotrigine: a review of its use in bipolar disorder. Drugs (2003) 63(19):2029-2050.
   PubMed Web of Science ®Google Scholar
• CHANG K, SAXENA K, HOWE M: An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):298-304.
   PubMed Web of Science ®Google Scholar
• MCELROY SL, KECK PE Jr: Pharmacologic agents for the treatment of acute bipolar mania. Biol. Psychiatry (2000) 48(6):539-557.
   PubMed Web of Science ®Google Scholar
• PANDE AC, POLLACK MH, CROCKATT J et al.: Placebo-controlled study of gabapentin treatment of panic disorder. J. Clin. Psychopharmacol. (2000) 20:467-471.
   PubMed Web of Science ®Google Scholar
• PANDE AC, DAVIDSON JR, JEFFERSON JW et al.: Treatment of social phobia with gabapentin: a placebo-controlled study. J. Clin. Psychopharmacol. (1999) 19:341-348.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, KOWATCH RA, WARNER J et al.: Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review. J. Child Adolesc. Psychopharmacol. (2002) 12(4):323-330.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, FINDLING RL, KUSHNER S et al.: A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(6):539-547.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, SCHWIERS ML, ROSENBERG HL et al.: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(10):1216-1223.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, KOWATCH RA, ADLER CM et al.: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):305-313.
   PubMed Web of Science ®Google Scholar
• SOUTULLO CA, SORTER MT, FOSTER KD, MCELROY SL, KECK PE: Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J. Affect. Disord. (1999) 53(3):279-283.
   PubMed Web of Science ®Google Scholar
• FRAZIER JA, BIEDERMAN J, TOHEN M et al.: A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. (2001) 11(3):239-250.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, MICK E, HAMMERNESS P et al.: Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol. Psychiatry (2005) 58(7):589-594.
   PubMed Web of Science ®Google Scholar
• TOHEN M, KRYZHANOVSKAYA L, CARLSON G et al.: Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder: a 3-week randomized double-blind placebo-controlled study. 44th Annual Meeting of the American College of Neuropsychopharmacology. Kohala, HI (13 December 2005) (2005).
   Google Scholar
• Frazier JA, Meyer MC, Biederman J et al.: Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(8):960-965.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, MICK E, WOZNIAK J et al.: An open-label trial of risperidone in children and adolescents with bipolar disorder. J. Clin. Adolesc. Psychiatry (2005) 15(2):311-317.
   Google Scholar
• MASI G, MUCCI M, MILLEPIEDI S: Clozapine in adolescent inpatients with acute mania. J. Child Adolesc. Psychopharmacol. (2002) 12(2):93-99.
   PubMed Web of Science ®Google Scholar
• SCHULTE PF: Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann. Pharmacother. (2006) 40(4):683-688.
   PubMed Web of Science ®Google Scholar
• KILLIAN JG, KERR K, LAWRENCE C et al.: Myocarditis and cardiomyopathy associated with clozapine. Lancet (1999) 354(9193):1841-1845.
   PubMed Web of Science ®Google Scholar
• BARNETT MS: Ziprasidone monotherapy in pediatric bipolar disorder. J. Child. Adolesc. Psychopharmacol. (2004) 14(3):471-477.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, MCDONNELL MA, WOZNIAK J et al.: Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr. (2005) 10(2):141-148.
   PubMed Web of Science ®Google Scholar
• CORRELL CU, CARLSON HE: Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(7):771-791.
   PubMed Web of Science ®Google Scholar
• YUMRU M, SAVAS HA, KURT E et al.: Atypical antipsychotics related metabolic syndrome in bipolar patients. J. Affect. Disord. (2006) 98(3):247-252.
   Google Scholar
• AMERICAN DIABETES ASSOCIATION: American psychiatric association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 27(2):596-601.
   Google Scholar
• FRISTAD MA, GOLDBERG-ARNOLD JS, GAVAZZI SM: Multifamily psychoeducation groups (MFPG) for families of children with bipolar disorder. Bipolar Disord. (2002) 4:254-262.
   PubMed Web of Science ®Google Scholar
• PAVULURI MN, GRACZYK PA, HENRY DB, CARBRAY JA, HEIDENREICH J, MIKLOWITZ DJ: Child and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43:528-537.
   PubMed Web of Science ®Google Scholar
• MIKLOWITZ DJ, GEORGE EL, AXELSON DA et al.: Family-focused treatment for adolescents with bipolar disorder. J. Affect. Disord. (2004) 82(Suppl 1):S113-S128.
   PubMed Web of Science ®Google Scholar
• KAPLAN BJ, FISHER JE, CRAWFORD SG, FIELD CJ, KOLB B: Improved mood and behavior during treatment with a mineral–vitamin supplement: an open-label case series of children. J. Child Adolesc. Psychopharmacol. (2004) 14(1):115-122.
   PubMed Web of Science ®Google Scholar
• KAPLAN BJ, SIMPSON JS, FERRE RC, GORMAN CP, MCMULLEN DM, CRAWFORD SG: Effective mood stabilization in bipolar disorder with a chelated mineral supplement. J. Clin. Psychiatry (2001) 62:936-944.
   PubMed Web of Science ®Google Scholar
• GHAZIUDDIN N, KUTCHER SP, KNAPP P et al.: Practice parameter for use of electroconvulsive therapy with adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43(12):1521-1539.
   PubMed Web of Science ®Google Scholar
• KAMPANI S, PAVULURI MN: Integrating pharmacotherapy and psychotherapy for paediatric bipolar disorder: translating science to service. J. Indian Assoc. Child Adolesc. Mental Health (2005) 1(2):2.
   Google Scholar
• KOWATCH RA, FRISTAD M, BIRMAHER B, WAGNER KD, FINDLING RL, HELLANDER M: Child psychiatric workgroup on bipolar disorder: treatment guidelines for children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(3):213-235.
   PubMed Web of Science ®Google Scholar
• PATEL NC, DELBELLO MP, BRYAN HS et al.: Open-label lithium for the treatment of adolescents with bipolar depression. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):289-297.
   PubMed Web of Science ®Google Scholar
• DANDO TM, KEATING GM: Spotlight on quetiapine in acute mania and depression associated with bipolar disorder. CNS Drugs (2006) 20(5):429-431.
   PubMedGoogle Scholar
• BIEDERMAN J, MICK E, SPENCER TJ, WILENS TE, FARAONE SV: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J. Child Adolesc. Psychopharmacol. (2000) 10:185-192.
   PubMed Web of Science ®Google Scholar
• BAUMER FM, HOWE M, GALLELLI K, SIMEONOVA DI, HALLMAYER J, CHANG KD: A pilot study of antidepressant-induced mania in pediatric bipolar disorder: characteristics, risk factors, and the serotonin transporter gene. Biol. Psychiatry (2006) 60(9):1005-1012.
   PubMed Web of Science ®Google Scholar
• KAFANTARIS V, COLETTI DJ, DICKER R, PADULA G, KANE JM: Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40(12):1448-1456.
   PubMed Web of Science ®Google Scholar
• PAVULURI MN, HENRY DB, CARBRAY JA et al.: Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J. Affect. Disord. (2004) 82(Suppl. 1):S103-S111.
   PubMedGoogle Scholar
• GALANTER CA, CARLSON GA, JENSEN PS et al.: Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J. Child Adolesc. Psychopharmacol. (2003) 13(2):123-136.
   PubMed Web of Science ®Google Scholar
• GAO K, MUZINA D, GAJWANI P, CALABRESE JR: Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J. Clin. Psychiatry (2006) 67(9):1327-1340.
   PubMed Web of Science ®Google Scholar
• FINDLING RL, MCNAMARA NK, YOUNGSTROM EA et al.: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(5):409-417.
   PubMed Web of Science ®Google Scholar
• FINDLING RL, MCNAMARA NK, STANSBREY R et al.: Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(2):142-148.
   PubMed Web of Science ®Google Scholar